Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raghavan Varadarajan

Showing results (121-130 of 145) with videos related to

Pageof 15
Sort By:
Journal of Virology|October 20, 2023
Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its conformation, fusogenicity, and neutralization sensitivitySahil Kumar, Rathina Delipan, Debajyoti Chakraborty, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2014
Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protectionVamsee V A Mallajosyula, Michael Citron, Francesca Ferrara, et al.
Science Advances|June 16, 2020
VapBC22 toxin-antitoxin system from <i>Mycobacterium tuberculosis</i> is required for pathogenesis and modulation of host immune responseSakshi Agarwal, Arun Sharma, Rania Bouzeyen, et al.
Journal of Virology|January 15, 2005
Characterization of gp120 and its single-chain derivatives, gp120-CD4D12 and gp120-M9: implications for targeting the CD4i epitope in human immunodeficiency virus vaccine designRaghavan Varadarajan, Deepak Sharma, Kausik Chakraborty, et al.
Plos Pathogens|May 1, 2023
Identification of diphenylurea derivatives as novel endocytosis inhibitors that demonstrate broad-spectrum activity against SARS-CoV-2 and influenza A virus both in vitro and in vivoNirmal Kumar, Irshad Maajid Taily, Charandeep Singh, et al.
Frontiers in Immunology|April 18, 2018
Evolution of Neutralization Response in HIV-1 Subtype C-Infected Individuals Exhibiting Broad Cross-Clade Neutralization of HIV-1 StrainsNarayanaiah Cheedarla, Babu Hemalatha, Brahmaiah Anangi, et al.
The Journal of Biological Chemistry|August 11, 2018
Bacterially expressed HIV-1 gp120 outer-domain fragment immunogens with improved stability and affinity for CD4-binding site neutralizing antibodiesUjjwal Rathore, Mansi Purwar, Venkada Subramanian Vignesh, et al.
Nature Chemical Biology|June 2, 2022
A dimeric proteomimetic prevents SARS-CoV-2 infection by dimerizing the spike proteinBhavesh Khatri, Ishika Pramanick, Sameer Kumar Malladi, et al.
The Journal of Biological Chemistry|November 24, 2016
Structure-based Design of Cyclically Permuted HIV-1 gp120 Trimers That Elicit Neutralizing AntibodiesSannula Kesavardhana, Raksha Das, Michael Citron, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challengeGayathri Bommakanti, Michael P Citron, Robert W Hepler, et al.
Pageof 15

Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
Journal of Virology|October 20, 2023
Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its conformation, fusogenicity, and neutralization sensitivitySahil Kumar, Rathina Delipan, Debajyoti Chakraborty, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 14, 2014
Influenza hemagglutinin stem-fragment immunogen elicits broadly neutralizing antibodies and confers heterologous protectionVamsee V A Mallajosyula, Michael Citron, Francesca Ferrara, et al.
Science Advances|June 16, 2020
VapBC22 toxin-antitoxin system from <i>Mycobacterium tuberculosis</i> is required for pathogenesis and modulation of host immune responseSakshi Agarwal, Arun Sharma, Rania Bouzeyen, et al.
Journal of Virology|January 15, 2005
Characterization of gp120 and its single-chain derivatives, gp120-CD4D12 and gp120-M9: implications for targeting the CD4i epitope in human immunodeficiency virus vaccine designRaghavan Varadarajan, Deepak Sharma, Kausik Chakraborty, et al.
Plos Pathogens|May 1, 2023
Identification of diphenylurea derivatives as novel endocytosis inhibitors that demonstrate broad-spectrum activity against SARS-CoV-2 and influenza A virus both in vitro and in vivoNirmal Kumar, Irshad Maajid Taily, Charandeep Singh, et al.
Frontiers in Immunology|April 18, 2018
Evolution of Neutralization Response in HIV-1 Subtype C-Infected Individuals Exhibiting Broad Cross-Clade Neutralization of HIV-1 StrainsNarayanaiah Cheedarla, Babu Hemalatha, Brahmaiah Anangi, et al.
The Journal of Biological Chemistry|August 11, 2018
Bacterially expressed HIV-1 gp120 outer-domain fragment immunogens with improved stability and affinity for CD4-binding site neutralizing antibodiesUjjwal Rathore, Mansi Purwar, Venkada Subramanian Vignesh, et al.
Nature Chemical Biology|June 2, 2022
A dimeric proteomimetic prevents SARS-CoV-2 infection by dimerizing the spike proteinBhavesh Khatri, Ishika Pramanick, Sameer Kumar Malladi, et al.
The Journal of Biological Chemistry|November 24, 2016
Structure-based Design of Cyclically Permuted HIV-1 gp120 Trimers That Elicit Neutralizing AntibodiesSannula Kesavardhana, Raksha Das, Michael Citron, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 10, 2010
Design of an HA2-based Escherichia coli expressed influenza immunogen that protects mice from pathogenic challengeGayathri Bommakanti, Michael P Citron, Robert W Hepler, et al.
Pageof 15